<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230709058729N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-07-13</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>" the Effect of the White noise on Behavioral Responses of Premature Infants"                                                                              "the Effect Sound reduction on Behavioral Responses of Premature Infants "</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the Effect of the White noise and Sound reduction on Behavioral Responses of Premature Infants under Non-invasive Ventilation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71255</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Blocked.
{ This method is used to prevent significant imbalances in the number of participants assigned to each group. Block randomization ensures that there is no significant imbalance between groups during randomization and at certain points the number of participants in each group is equal.Then write the list of blocks and assign numbers to them. ( AABB(1)- ABAB(2)-ABBA(3)-BBAA(4)- BABA(5)- BAAB(6)) .Then select random numbers between 1 to 6( for example 
 1  4  5 ...)  and finally specify the treatment allocation list based on the previous random numbers ( … AABB-BBAA-BABA-) .}, Blinding description: Participants are premature infants and consent is obtained from their parents, so infants are unaware and are blind.
The analyst is a statistical consultant who analyzes the data collected during the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>behavioral responses of premature infants.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This study is a randomized clinical trial with cross-sectional design. The cross design used in this study is standard cross design 2x2 BA/AB). 32 preterm infants in the range of 28-36 weeks will be included in the study under non-invasive ventilation in NICU of Hakim Hospital of Neyshabur who meet the inclusion criteria.Behavioral responses of preterm infants will be assessed and recorded 2 minutes before intervention, 2 minutes during and 2 minutes after intervention using Anderson's Behavioral Response Scoring System (ABSS). It should be noted that the time to observe and evaluate the behavior of the infant is 30 seconds at each stage. Intervention 2: Control group: In standard crossover design (BA/AB  2 x2), the infants in the intervention group are self-control.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is "There is no more information."</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahdieh Mohseni kakhki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashhad Faculty of medical scienses ,chaharrah doctora street</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9183793577</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>mohsenikm4012@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Monir Ramezani Farmad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>doctor Crossroads (Intersection of Ibn Sina Street and Daneshgah)</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9183793577</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>Ramezanimn@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Parental Consent for Infant Participation in Research
The baby's age ranges from 28 to 36 weeks and 6 days (based on LMP or ultrasound)
Be under non-invasive ventilation and have not been at most 24 hours since the onset of non-invasive ventilation
No invasive action was taken on the infant 2 hours before entering the study.
Normality of OAE test
No Counter-Indication to Change Positions
Lack of drug use in the mother during pregnancy and after childbirth
Not taking medications that affect the baby's sleep-wake cycle, such as theophylline, phenobarbital
Lack of sedatives such as midazolam and fentanyl
Absence of congenital abnormalities such as meningocele and meningomyelocele, meningitis, seizures, encephalopathy, congenital anomalies, asphyxia, intracranial hemorrhage greater than first-degree, sepsis, heart disease, metabolic and anemia.
The baby is not SGA or IUGR.
Having an Apgar score of 5 minutes above 6
Surgery on the baby after birth.</inclusion_criteria>
      <agemin>28 days</agemin>
      <agemax>36 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Poor baby (loss of consciousness, spo2 drop and change of vital signs from normal range)
Dissatisfaction of the parent of the guardian to the continuation of the infant's participation in the research
Infant death during the study
Infant Transfer
Need for invasive procedures during intervention
Prescription of sedative drugs during intervention
Developing neurological disorders such as seizures, grade 3 and 4 ventricular bleeding, sepsis
Need for surgery
Severe medical conditions that require the use of treatments such as sedatives, muscle relaxants, and analgesic medications
Performing LP in baby
Inappropriate medical condition, such as an unstable clinical condition
Need for surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This study is a randomized clinical trial with cross-sectional design. The cross design used in this study is standard cross design 2x2 BA/AB). 32 preterm infants in the range of 28-36 weeks will be included in the study under non-invasive ventilation in NICU of Hakim Hospital of Neyshabur who meet the inclusion criteria.Behavioral responses of preterm infants will be assessed and recorded 2 minutes before intervention, 2 minutes during and 2 minutes after intervention using Anderson's Behavioral Response Scoring System (ABSS). It should be noted that the time to observe and evaluate the behavior of the infant is 30 seconds at each stage.</i_keyword>
      <i_keyword>Control group: In standard crossover design (BA/AB  2 x2), the infants in the intervention group are self-control</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Behavioral response score of premature infant. Timepoint: Behavioral response score of preterm infant 2 minutes before, during and 2 minutes after intervention. Method of measurement: Infant Behavioral Reactions Registration Form Using Anderson Behavioral Response Scoring System (ABSS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-07</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Faculty of Nursing and Midwifery located at the intersection of Doctora (Ibn Sina St. and University) Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
